Overexpression of CCDC69 activates p14ARF/MDM2/p53 pathway and confers cisplatin sensitivity.
Long CuiFang ZhouCui ChenChi Chiu WangPublished in: Journal of ovarian research (2019)
It is tempting to conclude that targeting CCDC69 may play a role in cisplatin resistance.